Have your own idea? Try our Stock Screener
Polish (WIG) Life Sciences Industry Analysis
UpdatedJul 19, 2025
DataAggregated Company Financials
Companies5
- 7D6.6%
- 3M5.5%
- 1Y-40.6%
- YTD-27.2%
Over the last 7 days, the Life Sciences industry has risen 6.6%, driven by gains from every company within the industry. However, the industry is down 41% over the past year. Looking forward, earnings are forecast to grow by 60% annually.
Industry Valuation and Performance
Has the Polish Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 20 Jul 2025 | zł1.5b | zł461.1m | -zł128,888,382.00 | 39.8x | -11.6x | 3.3x |
| Tue, 17 Jun 2025 | zł1.3b | zł457.8m | -zł130,948,382.00 | n/a | -10x | 2.9x |
| Thu, 15 May 2025 | zł1.7b | zł452.3m | -zł123,092,243.00 | 49.3x | -14x | 3.8x |
| Sat, 12 Apr 2025 | zł1.4b | zł452.3m | -zł123,092,243.00 | 49.3x | -11.1x | 3x |
| Mon, 10 Mar 2025 | zł1.5b | zł430.1m | -zł55,602,243.00 | 32.4x | -27.1x | 3.5x |
| Wed, 05 Feb 2025 | zł1.6b | zł427.8m | -zł64,267,017.00 | 14.7x | -25.2x | 3.8x |
| Fri, 03 Jan 2025 | zł2.0b | zł427.0m | -zł65,964,174.00 | 17.1x | -31.1x | 4.8x |
| Sun, 01 Dec 2024 | zł2.2b | zł427.1m | -zł66,300,174.00 | 17.3x | -32.6x | 5.1x |
| Tue, 29 Oct 2024 | zł2.3b | zł413.2m | -zł64,500,689.00 | 21.4x | -35.9x | 5.6x |
| Thu, 26 Sep 2024 | zł2.4b | zł421.4m | -zł39,488,869.00 | 15.9x | -59.7x | 5.6x |
| Sat, 24 Aug 2024 | zł2.4b | zł413.4m | -zł37,576,869.00 | 17.1x | -63.2x | 5.7x |
| Mon, 22 Jul 2024 | zł2.4b | zł413.5m | -zł32,092,283.00 | 18.6x | -74.7x | 5.8x |
| Wed, 19 Jun 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 17.9x | -76.8x | 6x |
| Fri, 17 May 2024 | zł2.6b | zł421.0m | -zł26,364,957.00 | 18.3x | -99.3x | 6.2x |
| Sun, 14 Apr 2024 | zł2.7b | zł421.0m | -zł26,364,957.00 | 18.9x | -100.7x | 6.3x |
| Tue, 12 Mar 2024 | zł2.6b | zł495.9m | -zł52,637,957.00 | 45.9x | -48.8x | 5.2x |
| Thu, 08 Feb 2024 | zł2.6b | zł495.2m | -zł50,454,191.00 | 44.7x | -50.8x | 5.2x |
| Sat, 06 Jan 2024 | zł2.5b | zł495.2m | -zł50,454,191.00 | 44.2x | -48.7x | 5x |
| Mon, 04 Dec 2023 | zł2.6b | zł495.2m | -zł50,483,342.00 | 47.4x | -51.7x | 5.3x |
| Wed, 01 Nov 2023 | zł2.7b | zł512.0m | -zł37,354,934.00 | 32.8x | -71.3x | 5.2x |
| Fri, 29 Sep 2023 | zł2.7b | zł515.2m | -zł42,853,934.00 | 37.9x | -63x | 5.2x |
| Sun, 27 Aug 2023 | zł2.7b | zł507.8m | -zł51,598,105.00 | 43.2x | -51.9x | 5.3x |
| Tue, 25 Jul 2023 | zł2.9b | zł512.4m | -zł61,559,268.00 | 45.3x | -46.4x | 5.6x |
| Thu, 22 Jun 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 44.5x | -45.8x | 5.5x |
| Sat, 20 May 2023 | zł2.9b | zł516.9m | -zł55,982,034.00 | 72.6x | -51.4x | 5.6x |
| Mon, 17 Apr 2023 | zł2.9b | zł505.4m | -zł64,921,034.00 | 68.2x | -44x | 5.6x |
| Wed, 15 Mar 2023 | zł3.1b | zł473.8m | -zł77,860,781.00 | 80.6x | -40.2x | 6.6x |
| Fri, 10 Feb 2023 | zł3.0b | zł483.0m | -zł79,277,613.00 | 61.2x | -38x | 6.2x |
| Sun, 08 Jan 2023 | zł2.9b | zł483.0m | -zł79,277,613.00 | 58.8x | -36.7x | 6x |
| Tue, 06 Dec 2022 | zł2.6b | zł473.4m | -zł84,749,643.00 | 35x | -30.9x | 5.5x |
| Thu, 03 Nov 2022 | zł2.4b | zł445.7m | -zł96,033,392.00 | 60.7x | -24.7x | 5.3x |
| Sat, 01 Oct 2022 | zł2.3b | zł443.7m | -zł83,357,892.00 | 63x | -27.3x | 5.1x |
| Mon, 29 Aug 2022 | zł2.2b | zł409.8m | -zł84,484,453.00 | 62.1x | -25.8x | 5.3x |
| Wed, 27 Jul 2022 | zł2.1b | zł417.3m | -zł76,832,012.00 | 54x | -27.1x | 5x |
Price to Earnings Ratio
-27.1x
Current Industry PE
- Investors are pessimistic on the Polish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.2x is higher than the industry's current PS ratio of 3.3x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 3.4% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | 2.93% | |
| Healthcare | 3.79% | |
| Life Sciences | 6.55% | |
| Clinical Research and Equipment | 6.55% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SLV Selvita | zł31.80 | 11.6% +zł60.6m | -52.0% | PS1.6x | |
| RVU Ryvu Therapeutics | zł31.55 | 2.4% +zł17.3m | -35.9% | PS7.5x | |
| HEN HyEnergy | zł2.44 | 15.6% +zł11.1m | 37.9% | PE39.8x | |
| MDB Medicofarma Biotech | zł0.31 | 11.3% +zł2.1m | -33.2% | PS44.8x | |
| NNG NanoGroup | zł2.64 | 1.3% +zł1.1m | 5.4% | PS833623.4x |